About
He holds an MBA from the University of Miami School of Business and a BBA in finance and international marketing and management from the University of Georgia Terry College of Business, and he completed the Advanced Management Program at Harvard Business School. Before Zimmer Biomet he spent more than ten years at Johnson & Johnson and held roles at Baxter International, Covidien and C. R. Bard. At Becton, Dickinson and Company (BD), now led by Tom Polen, he was a worldwide president for urology, medical and critical care from 2017 to 2018. Other medical technology chief executives on Whoo include Geoff Martha and Kevin Lobo.
Whoo compiled this page from public sources: Zimmer Biomet 2026 proxy statement (SEC), Zimmer Biomet leadership page, Wikipedia. It is not affiliated with or endorsed by Ivan Tornos. Are you Ivan Tornos? Claim this page, or write to [email protected] to correct or remove it. Last updated: 2026-11-18.
Want a page like this? Create yours from your résumé.
Experience
Chairman, President and Chief Executive Officer — Zimmer Biomet
August 2023 – Present
- President and CEO and board member since August 2023
- Named Chairman of the board in May 2025
Chief Operating Officer — Zimmer Biomet
March 2021 – August 2023
Group President, Global Businesses and the Americas — Zimmer Biomet
December 2019 – March 2021
Group President, Orthopedics — Zimmer Biomet
November 2018 – December 2019
Worldwide President, Global Urology, Medical and Critical Care — BD
June 2017 – October 2018
President, Europe, Middle East and Africa — C. R. Bard
2013 – 2017